Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Boston-based Massachusetts General Hospital is one of many hospitals nationwide grappling with a severe shortage of intravenous opioids.
The FDA has approved a detection device from BacterioScan, a St. Louis biotech startup, which can quickly diagnose patients with urinary tract infections, according to St. Louis Public Radio.
About 90 percent of emergency physicians have experienced shortages or absences of critical medications in their emergency departments in the last month, according to a recent poll conducted by the American College of Emergency Physicians.
The salaries of supply chain professionals increased faster than overall U.S. wage gains in 2017, according to data from the Institute for Supply Management cited by The Wall Street Journal.
Pfizer earned FDA approval for its drug Retacrit — a biosimilar version of the anemia therapy Epogen/Procrit — May 15.
Amgen will charge $6,900 per year for its migraine prevention drug — a price 30 percent lower than Wall Street expectations — as the company attempts to dodge the payer backlash that has affected recent drug launches, according to STAT.
The FDA on May 16 released a list of drug companies that may be using "gaming tactics" to delay generic competition from hitting the market.
Vermont Republican Gov. Phil Scott signed a bill May 16 to permit the importation of cheaper prescription drugs from Canada, reports Politico.
James Harrison, an 81-year-old Australian man, has donated his blood every few weeks for the past 60 years, helping save millions of newborns' lives, reports The New York Times.
Janssen Biotech and Pharmacyclics withdrew a proposed plan to introduce a new version of their blood cancer drug Imbruvica at triple the cost of the original, reports The Washington Post.